{"database": "openregs", "table": "documents", "rows": [["FDA-2025-N-5935-0001", "FDA", "FDA-2025-N-5935", "Intercept Pharmaceuticals, Inc., et al.; Withdrawal of Approval of New Drug Application for OCALIVA (Obeticholic Acid) Tablets, 5 Milligrams and 10\nMilligrams, and Three Abbreviated New Drug Applications for Obeticholic Acid Tablets, 5 Milligrams and 10 Milligrams", "Notice", "Withdrawal", "2025-11-24T05:00:00Z", 2025, 11, "2025-11-24T05:00:00Z", null, "2025-11-24T18:52:14Z", "2025-20767", 0, 0, "09000064b90936f4"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2025-N-5935-0001"], "units": {}, "query_ms": 0.3755149955395609, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}